South-East Asia (WHO region) vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB

South-East Asia (WHO region)
91.0%
in 2024
Saint Vincent and the Grenadines
100.0%
in 2023
South-East Asia (WHO region) rank
1st
Saint Vincent and the Grenadines rank
1st

New cases tested for RR-/MDR-TB over time

  • South-East Asia (WHO region)
  • Saint Vincent and the Grenadines
020406080100200520142024

How they compare

Saint Vincent and the Grenadines currently reports 100.0% against 91.0% in South-East Asia (WHO region), a difference of 9.0%.

That makes Saint Vincent and the Grenadines's figure about 1.1 times South-East Asia (WHO region)'s.

The two have swapped places 2 times across 13 shared years of data; in 2005 it was Saint Vincent and the Grenadines ahead.

South-East Asia (WHO region) ranks 1st and Saint Vincent and the Grenadines ranks 1st of 11 groups.

Saint Vincent and the Grenadines has averaged higher in every one of the 3 decades both report.

Head to head by decade

Decade South-East Asia (WHO region) Saint Vincent and the Grenadines Difference Ahead
2000s 0.1% 86.0% 85.9% Saint Vincent and the Grenadines
2010s 14.9% 72.8% 57.8% Saint Vincent and the Grenadines
2020s 74.5% 75.0% 0.5% Saint Vincent and the Grenadines

Averages of every year both report within each decade.

Frequently asked questions

Which has higher new cases tested for rr-/mdr-tb, South-East Asia (WHO region) or Saint Vincent and the Grenadines?
Saint Vincent and the Grenadines, at 100.0% against 91.0% in South-East Asia (WHO region) as of 2023.
What is the difference in new cases tested for rr-/mdr-tb between South-East Asia (WHO region) and Saint Vincent and the Grenadines?
9.0%, with Saint Vincent and the Grenadines ahead.
How many years of comparable data are there for South-East Asia (WHO region) and Saint Vincent and the Grenadines?
13 years are reported by both, from 2005 to 2023.
How do South-East Asia (WHO region) and Saint Vincent and the Grenadines rank globally for new cases tested for rr-/mdr-tb?
South-East Asia (WHO region) ranks 1st and Saint Vincent and the Grenadines ranks 1st of 11 groups.
Where does this data come from?
World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.

Individual pages

Share, cite or embed this page

Cite this page

South-East Asia (WHO region) vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB. Statizoid, drawing on World Health Organization, Global Health Observatory. Retrieved 17 September 2026, from https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/south-east-asia-who-region/st-vincent-and-the-grenadines/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY-NC-SA 3.0 IGO (WHO); please keep the attribution.

<a href="https://health.statizoid.com/compare/new-cases-tested-for-rr-mdr-tb-percent/south-east-asia-who-region/st-vincent-and-the-grenadines/">South-East Asia (WHO region) vs Saint Vincent and the Grenadines: New cases tested for RR-/MDR-TB</a> — Statizoid

About this data

Indicator
New cases tested for RR-/MDR-TB (%)
Source
World Health Organization, Global Health Observatory
Licence
CC BY-NC-SA 3.0 IGO (WHO)
Coverage
205 places, 3,388 data points, 2005–2024
Last refreshed